Guy Griebel

16.5k total citations · 1 hit paper
174 papers, 12.0k citations indexed

About

Guy Griebel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Guy Griebel has authored 174 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cellular and Molecular Neuroscience, 63 papers in Molecular Biology and 55 papers in Behavioral Neuroscience. Recurrent topics in Guy Griebel's work include Stress Responses and Cortisol (55 papers), Neuroendocrine regulation and behavior (52 papers) and Neurotransmitter Receptor Influence on Behavior (50 papers). Guy Griebel is often cited by papers focused on Stress Responses and Cortisol (55 papers), Neuroendocrine regulation and behavior (52 papers) and Neurotransmitter Receptor Influence on Behavior (50 papers). Guy Griebel collaborates with scholars based in France, United States and Morocco. Guy Griebel's co-authors include Catherine Belzung, Ghislaine Perrault, Robert J. Blanchard, D. Caroline Blanchard, D. J. Sanger, Jeanne Stemmelin, Caroline Cohen, B. Scatton, Philippe Soubrié and Andrew Holmes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Reviews Drug Discovery and Scientific Reports.

In The Last Decade

Guy Griebel

174 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measuring normal and pathological anxiety-like behaviour in mice: a review

2001 716 citations Catherine Belzung, Guy Griebel profile →

Peers

Countries citing papers authored by Guy Griebel

Since Specialization

Citations

This map shows the geographic impact of Guy Griebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Griebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Griebel more than expected).

Fields of papers citing papers by Guy Griebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Griebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Griebel. The network helps show where Guy Griebel may publish in the future.

Co-authorship network of co-authors of Guy Griebel

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Griebel. A scholar is included among the top collaborators of Guy Griebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Griebel. Guy Griebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Further evidence for the sleep-promoting effects of 5-HT2A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats 2013 ·Neuropharmacology ·Guy Griebel, Sandra Beeské, (unknown), (unknown), Richard Alonso, M. Decobert, Patrick Avenet, Dominique Françon	13
2	AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents 2010 ·Psychopharmacology ·Mark D. Black, (unknown), (unknown), Robert E. Featherstone, Yaw Senyah, (unknown), Beth Borowsky, Jeanne Stemmelin, Caroline Cohen, Philippe Pichat, Michal Arad, Segev Barak, (unknown), Ina Weiner, Guy Griebel, Geoffrey B. Varty	41
3	Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression 2010 ·Pharmacology Biochemistry and Behavior ·David H. Overstreet, (unknown), Guy Griebel	17
4	Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal 2008 ·Biological Psychiatry ·Alexandre Surget, Michael Saxe, Samuel Leman, Yadira Ibargüen-Vargas, Sylvie Chalon, Guy Griebel, René Hen, Catherine Belzung	433
5	Influence of lipoprotein-lipase activity on plasma triacylglycerol concentration and lipid storage in three genotypes of ducks 2007 ·Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology ·Jean‐Marc André, Guy Griebel, (unknown), (unknown), (unknown), R. Hoo-Paris, S. Davail	27
6	Disruption of the Prepulse Inhibition of the Startle Reflex in Vasopressin V1b Receptor Knockout Mice: Reversal by Antipsychotic Drugs 2005 ·Neuropsychopharmacology ·Nobuaki Egashira, Akito Tanoue, (unknown), (unknown), Kazunori Sano, Kenichi Mishima, Yoshihiko Fukue, Hiroshi Nagai, Yukio Takano, Gozoh Tsujimoto, Jeanne Stemmelin, Guy Griebel, Katsunori Iwasaki, Tomoaki Ikeda, Ryoji Nishimura, Michihiro Fujiwara	41
7	Evidence that the Lateral Septum is Involved in the Antidepressant-Like Effects of the Vasopressin V1b Receptor Antagonist, SSR149415 2004 ·Neuropsychopharmacology ·Jeanne Stemmelin, (unknown), Nicolas Salomé, Guy Griebel	91
8	Fear and stress reactions in two species of duck and their hybrid 2003 ·Hormones and Behavior ·Jean-Michel Faure, David Val‐Laillet, Guy Griebel, Marie-Dominique Bernadet, Daniel D. Guemene	31
9	Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders 2002 ·Proceedings of the National Academy of Sciences ·Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal, Jean Wagnon, Marc Pascal, B. Scatton, Jean‐Pierre Maffrand, Philippe Soubrié	381
10	SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}-4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin 1 Receptor: II. Neurochemical and Behavioral Characterization 2002 ·Journal of Pharmacology and Experimental Therapeutics ·R. Steinberg, Richard Alonso, L. Rouquier, Christophe Desvignes, (unknown), Annie Cudennec, M. Jung, Jacques Simiand, Guy Griebel, Xavier Emonds‐Alt, Gérard Le Fur, Philippe Soubrié	30
11	Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand, Guy Griebel, C Lacour, Gilles Guillon, Claude Barberis, (unknown), Philippe Soubrié, Dino Nisato, Marc Pascal, Rebecca M. Pruss, B. Scatton, Jean‐Pierre Maffrand, Gérard Le Fur	180
12	Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery 2001 ·Neuroscience & Biobehavioral Reviews ·Guy Griebel, (unknown), (unknown), Jacques Simiand, (unknown)	22
13	Orphanin FQ, a novel neuropeptide with anti-stress-like activity 1999 ·Brain Research ·Guy Griebel, Ghislaine Perrault, D. J. Sanger	88
14	Behavioral Effects of Acute and Chronic Fluoxetine in Wistar–Kyoto Rats 1999 ·Physiology & Behavior ·Guy Griebel, Caroline Cohen, Ghislaine Perrault, (unknown)	75
15	Evidence that the Behaviors in the Mouse Defense Test Battery Relate to Different Emotional States: A Factor Analytic Study 1996 ·Physiology & Behavior ·Guy Griebel, D. Caroline Blanchard, Robert J. Blanchard	61
16	Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine 1995 ·Psychopharmacology ·Guy Griebel, D. Caroline Blanchard, Richard S. Agnes, Robert J. Blanchard	94
17	Genetic parameters from factorial cross breeding in two duck strains (Anas Platyrhynchos) brown Tsaiya and Pekin, for growth and fatty liver traits 1994 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), Guy Griebel, (unknown), (unknown)	2
18	Behavioral profile of the 5HT1A receptor antagonist (S)-UH-301 in rodents and monkeys 1992 ·Brain Research Bulletin ·Jean‐Luc Moreau, Guy Griebel, F. Jenck, James R. Martin, Ulrich Widmer, W. Haefely	54
19	Growth characteristics and lipid distribution in two lines of chicken selected for low or high abdominal fat 1989 ·Genetics Selection Evolution ·B. Leclercq, Guy Griebel, (unknown)	17
20	Evidence of Enhanced Storage Capacity in Adipose Tissue of Genetically Fat Chickens 1989 ·Journal of Nutrition ·Dominique Hermier, A. Quignard-Boulangé, Isabelle Dugail, Guy Griebel, (unknown), (unknown), B. Ardouin, B. Leclercq	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact